Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor

被引:19
作者
Ehlert, Frederick J. [1 ]
Griffin, Michael T. [2 ]
机构
[1] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA
[2] Champman Univ, Dept Phys Sci, Orange, CA USA
关键词
D O I
10.1124/jpet.108.136960
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We measured the influence of gallamine on the functional responses and binding properties of selected agonists at the M-2 muscarinic receptor and analyzed the data within the context of the allosteric ternary complex model. Our analysis showed that gallamine modified agonist affinity without influencing efficacy. To explain this behavior, we investigated the allosteric ternary complex model at a deeper level of analysis to assess allosterism in terms of the differential affinity of gallamine for ground and active states of the receptor. Our simulations showed that two-state models based on a single orthosteric site for the agonist linked to an allosteric site for gallamine could not account for affinity-only modulation, even if multiple conformations of ground and active states were considered. We also expanded the tandem two-site model (J Biol Chem 275: 18836-18844, 2000) within the context of the allosteric ternary complex model and analyzed the resulting hybrid model at the level of receptor states. This model posits that the agonist first binds to a relay site and then shuttles to the activation site to turn on the receptor. If it is assumed that allosterism occurs at the relay site and not the activation site, then this model can account for affinity- only modulation in a manner consistent with the allosteric ternary complex model.
引用
收藏
页码:1039 / 1060
页数:22
相关论文
共 40 条
[1]   Critical role for the second extracellular loop in the binding of both orthosteric and allosteric g protein-coupled receptor Ligands [J].
Avlani, Vimesh A. ;
Gregory, Karen J. ;
Morton, Craig J. ;
Parker, Michael W. ;
Sexton, Patrick M. ;
Christopoulos, Arthur .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (35) :25677-25686
[2]   Allosterism at muscarinic receptors: Ligands and mechanisms [J].
Birdsall, NJM ;
Lazareno, S .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) :523-543
[3]   THE EFFECT OF MCN-A-343 ON MUSCARINIC RECEPTORS IN THE CEREBRAL-CORTEX AND HEART [J].
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC ;
STOCKTON, JM ;
ZIGMOND, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (02) :257-259
[4]   OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors [J].
Christopoulos, A ;
Mitchelson, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 339 (2-3) :153-156
[7]   INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS [J].
CLARK, AL ;
MITCHELSON, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 58 (03) :323-331
[8]  
Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924
[9]   FAST EVENTS IN SINGLE-CHANNEL CURRENTS ACTIVATED BY ACETYLCHOLINE AND ITS ANALOGS AT THE FROG-MUSCLE ENDPLATE [J].
COLQUHOUN, D ;
SAKMANN, B .
JOURNAL OF PHYSIOLOGY-LONDON, 1985, 369 (DEC) :501-&
[10]   AN ALLOSTERIC MODEL FOR BENZODIAZEPINE RECEPTOR FUNCTION [J].
EHLERT, FJ ;
ROESKE, WR ;
GEE, KW ;
YAMAMURA, HI .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (16) :2375-2383